Urine test to monitor prostate or bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a simple urine test to see if it can monitor prostate or bladder cancer without needing invasive procedures. It aims to find out if the test can track how well treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that is high-risk and localized, and you are scheduled for high-dose radiation therapy.
- You have metastatic hormone-sensitive prostate cancer and are scheduled to receive docetaxel chemotherapy.
- You have metastatic castration-resistant prostate cancer and are in second-line treatment, scheduled to receive luPSMA treatment.
- You have localized bladder cancer and are scheduled to receive neoadjuvant chemotherapy before surgery.
- You have metastatic bladder cancer and are scheduled to receive a combination of enfortumab vedotin and pembrolizumab.
- You have not had any other cancer in the past 5 years (except for basal cell skin cancer or cervical carcinoma in situ).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
This study tests whether a protein called CREPT found in urine can help doctors diagnose bladder cancer or monitor patients who already have it. Researchers will compare urine samples from people with bladder cancer, people with other bladder conditions, and healthy volunteers.
This study is testing a new, non-invasive urine test that looks for specific DNA changes (methylation patterns) to find bladder cancer early. If you have bladder cancer or are a healthy person willing to help, you may be able to join.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This study tests a urine test that may help find bladder cancer early without needing invasive procedures. It is for people with high-grade or high-risk non-muscle-invasive bladder cancer who are receiving or have received BCG treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.